Hong Kong University Unveils Breakthrough AI Tools to Transform Cancer and Disease Diagnostics

The Hong Kong University of Science and Technology (HKUST) has launched four advanced AI tools designed to expedite diagnostics and enhance patient care across a broad range of cancers and diseases. The flagship models include MOME, a breast cancer diagnostic tool that leverages MRI data to identify malignant breast lumps, and mSTAR, a pathology assistant that streamlines 40 key diagnostic and prognostic tasks, both designed to achieve accuracy levels on par with experienced specialists. Together, these innovations aim to reduce invasive diagnostic procedures and optimize treatment planning, providing essential support to pathologists and oncologists.

​

Further enhancing healthcare efficiency, the MedDr tool functions as a multimodal assistant capable of generating medical reports, interpreting medical images, and supporting clinical decision-making. To address concerns about the transparency of AI models in healthcare, the XAIM model explains its diagnostic processes, empowering healthcare workers to adopt AI more confidently. This announcement positions HKUST as a pioneer in healthcare AI, with these tools set to not only boost diagnostic precision but also mitigate physician burnout—a primary factor contributing to industry inefficiencies.